Search
Nanose Medical
Nanose builds an AI-driven sensing platform that enables early risk detection of lung cancer and advanced liver fibrosis (MASLD/MASH) at the point of care.
Our proprietary sensing technology generates a biochemical breathprint from a 30-second sample with results in under 5 minutes, enabling scalable patient stratification upstream of the standard of care.
The platform’s non-invasive desi...
Source of information:
Add to My List
Key Executives
Ilay Marom
Co-founder & COO
Orit Marom Albeck
Co-Founder and CEO
Imad Telhami
Co-Founder & Board member
Industries
Recent News & Activity
